Alerts will be sent to your verified email
Verify Email
ACUTAAS
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Ami Organics Limited specializes in advanced pharmaceutical intermediates and key starting material for agrochemical and fine chemicals. They are a major manufacturer for key APIs like Dolutegravir and Rivaroxaban.
Acutaas Chemicals major competitors are Supriya Lifescience, Aether Industries, Alivus Life Sciences, Granules India, Shilpa Medicare, Aarti Pharmalabs, Neuland Laboratories.
Market Cap of Acutaas Chemicals is ₹11,571 Crs.
While the median market cap of its peers are ₹9,823 Crs.
Acutaas Chemicals seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Jul | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep | |||||||||||||
| Investor Presentation | May Jul | Mar May Jun Sep Dec | Mar Jun Sep Dec | Feb Mar May Jun Aug Sep Dec | Sep Dec | |||||||||||||
| Conference Call | Mar Jun | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Sep Dec | |||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
